BioWorld Science

March 29, 2022

View Archived Issues

New monoglyceride lipase inhibitors identified at Roche

LG Chem discovers diacylglycerol O-acyltransferase 2 inhibitors

Seoul National University Hospital patents triglyceride-lowering peptides

Friedrich-Alexander-University Erlangen-Nuremberg presents mu-opioid receptor agonists

New USP7 inhibitors identified at Shouyao Holdings

Elicio Therapeutics' TLR9 agonist AMP-CpG induces potent immune and antitumoral effects

PF-07038124: a topical PDE4 inhibitor for atopic dermatitis and plaque psoriasis

LNP formulation development and production service launched by eTheRNA Manufacturing

Artelo collaborates with Trinity College Dublin to better understand FABP inhibition in cancer

Flavonoids as nuclear receptor 4A1 ligands for treating rhabdomyosarcoma

Novel NR4A1 antagonists show antitumor activity in syngeneic mouse model of colon cancer

Gain-of-function study identifies T-cell boosters

23andme founder-led group outbids Regeneron for company

BioWorld

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2025.

Elevidys’ second liver death hits Sarepta, sends DMD ripples

BioWorld

How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 18, 2025.

3D representation of tumor microenvironment

EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment

BioWorld Science

Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...